According to Acadia Healthcare 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.2843. At the end of 2022 the company had a P/E ratio of 27.1.
Year | P/E ratio | Change |
---|---|---|
2022 | 27.1 | -4.53% |
2021 | 28.4 | -531.17% |
2020 | -6.58 | -124.75% |
2019 | 26.6 | -308.8% |
2018 | -12.7 | -189.32% |
2017 | 14.2 | -96.56% |
2016 | 414 | 1052.62% |
2015 | 35.9 | -12.03% |
2014 | 40.8 | -26.72% |
2013 | 55.7 | 24% |
2012 | 44.9 | -933.22% |
2011 | -5.39 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Universal Health Services
UHS | 18.6 | -16.51% | ๐บ๐ธ USA |
The Ensign Group ENSG | 26.7 | 19.66% | ๐บ๐ธ USA |
National Healthcare
NHC | 48.0 | 115.35% | ๐บ๐ธ USA |
Capital Senior Living
CSU | N/A | N/A | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.